| (210) | Number of the EPO application | 16738971 |
| (220) | Filing date of the EPO application | 2016.06.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 37/2025, 2025.09.10 |
| (110) | EPO patent number | 3317264 |
| (21) | Number of the application | e 2018 0480 |
| (71) | Name(s) of applicant(s), code of the country | Exelixis, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | BROWN Adrian St. Clair, GB; |
| (73) | Name(s) of owner(s), code of the country | Exelixis, Inc., US; |
| (54) | Title of the invention | CRYSTALLINE FUMARATE SALT OF (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)PHENYL][3-HYDROXY-3-(PIPERIDIN-2-YL) AZETIDIN-1-YL]-METHANONE |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 401/04 (2006.01.01); A61K 31/397 (2006.01.01); A61K 31/4427 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.06.30 |
| (30) | Priority | 201562187009 P, 2015.06.30, US |
| (86) | International application | PCT/US2016/040444, 2016.06.30 |
| (87) | International publication | WO 2017/004393, 2017.01.05 |